Latest data shows that the global healthcare e-commerce market will be valued about $732 billion by the year 2027. It is expected that during this period, the healthcare industry will grow significantly. Below, we look at some of the trends that will shape this market’s future.
Greater focus on automation, data and technology
Businesses involved in the healthcare industry have until the end of this year to start observing requirements under the Drug Supply Chain Security Act, which entail managing data on transaction details throughout the supply chain. This data will, in addition to ensuring compliance, assist suppliers to predict inventory needs and prepare for future changes in flow of products.
Healthcare buyers want more online capabilities
A growing number of consumers are seeking more information such as product details, pricing information, stock availability insights and quotes online; they are also buying more products on online platforms. One recent study found that roughly 90% of buyers of healthcare equipment choose their suppliers online.
To help meet consumer needs, many business-to-business medical supply clients are adopting/plan to adopt e-commerce, which will decrease administrative overheads, increase efficiency of the buying process and improve consumer satisfaction, among other benefits.
Suppliers of healthcare are merging the supply chain, embracing direct-to-consumer sales
At the moment, the business models of healthcare suppliers rely on sales representatives and distributors. This is backed by a survey which found that 73% of all hospitals and health systems still buy most of their medical supplies through distributors. While the added costs incurred on these models are manageable for bigger businesses, they’re unsustainable for smaller organizations. To minimize these costs, some businesses are adopting direct-to-consumer online sales.
Amazon’s market share will increase
For almost a decade, Amazon has been conducting experimental projects in the digital healthcare space, with a focus on leveraging artificial intelligence (“AI”). Some of its underground projects include Amazon X, the Amazon Grand Challenge and 1492. In addition, the company has ventured into e-healthcare, beginning with the launch of online medical supply sales and leveraging machine learning to cure and prevent cancer.
It is expected that as Amazon partners with industry leaders and takes part in various projects, the company will gain even more ground in healthcare e-commerce.
The use of personalization, AI will grow
Suppliers personalizing their ads to provide better product suggestions and target consumers more efficiently may soon become the norm. Personalization will also help build consumer trust, which is a good building block for a successful online sales channel.
As more companies such as NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) enter the healthcare ecommerce space and introduce a range of innovative products, a time may come when most transactions within the healthcare system are conducted via online platforms.
NOTE TO INVESTORS: The latest news and updates relating to NextPlat Corp. (NASDAQ: NXPL) are available in the company’s newsroom at https://ibn.fm/NXPL
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
Doctors in Spain recently handled a fascinating yet terrifying case of a patient that developed brain cancer-like symptoms and…
While immunotherapy is revolutionizing cancer therapy, response rates to these novel treatments are low and some patients…
Regentis recently received European regulatory approval for a next-generation GelrinC manufacturing process that increases production…
The company has advanced its VXA-222 bispecific antibody-drug conjugate (“bsADC”) program into the next stage…
As July came to an end, the United States reached an undesirable milestone: exceeding the…
Scientists and public health experts are warning that climate change is accelerating the rate at which infectious…